Literature DB >> 16926926

Use of neuroleptics: study of institutionalized elderly people in Montreal, Que.

Nathalie Champoux1, Johanne Monette, Michèle Monette, Guillaume Galbaud du Fort, Christina Wolfson, Jean-Pierre Le Cruguel.   

Abstract

OBJECTIVE: To determine the prevalence of neuroleptic use in long-term care institutions in the greater Montreal, Que, area and to estimate the extent of use of atypical neuroleptics.
DESIGN: Cross-sectional study in which single-day chart reviews were conducted to evaluate the prevalence of use of conventional and atypical neuroleptics.
SETTING: Ten long-term care institutions in the greater Montreal area. PARTICIPANTS: Two thousand, four hundred sixty residents aged 65 years or older living in 10 long-term care institutions in and around Montreal. MAIN OUTCOME MEASURES: Single-day medication profiles compiled by institutions' pharmacists.
RESULTS: Among patients in the 10 participating institutions, use of neuroleptics ranged from 15% to 37% with a mean of 25.2% (620/2460). Atypical neuroleptics were prescribed to 15.6%, conventional neuroleptics to 7.6%, and a combination of both to 2.0% of the 2460 patients.
CONCLUSION: Use of neuroleptics was relatively prevalent, and there was wide use of atypical neuroleptics in Montreal-area long-term care institutions. There is little information on the safety and efficacy of these medications for institutionalized elderly people.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16926926      PMCID: PMC1472929     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  33 in total

1.  [Use of psychopharmaceuticals in municipal nursing homes. A nationwide survey].

Authors:  J Tybjerg; N C Gulmann
Journal:  Ugeskr Laeger       Date:  1992-11-02

2.  Risperidone for dementia-related disturbed behavior in nursing home residents: a clinical experience.

Authors:  R J Goldberg; J Goldberg
Journal:  Int Psychogeriatr       Date:  1997-03       Impact factor: 3.878

3.  Mental illness and psychotropic medication use in the nursing home.

Authors:  G Arling; B J Ryther; T Collins; D Zimmerman
Journal:  J Aging Health       Date:  1991-11

4.  Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.

Authors:  J Avorn; R L Bohn; H Mogun; J H Gurwitz; M Monane; D Everitt; A Walker
Journal:  Am J Med       Date:  1995-07       Impact factor: 4.965

5.  Psychotropic drug use in Sydney nursing homes.

Authors:  J Snowdon; R Vaughan; R Miller; E E Burgess; P Tremlett
Journal:  Med J Aust       Date:  1995-07-17       Impact factor: 7.738

6.  Aggression in the demented patient: a double-blind study of loxapine versus haloperidol.

Authors:  W Carlyle; R J Ancill; L Sheldon
Journal:  Int Clin Psychopharmacol       Date:  1993       Impact factor: 1.659

7.  Clinical assessment of extrapyramidal signs in nursing home patients given antipsychotic medication.

Authors:  J Avorn; M Monane; D E Everitt; M H Beers; D Fields
Journal:  Arch Intern Med       Date:  1994-05-23

8.  Risperidone in the treatment of schizophrenia.

Authors:  S R Marder; R C Meibach
Journal:  Am J Psychiatry       Date:  1994-06       Impact factor: 18.112

9.  Canadian study of health and aging: study methods and prevalence of dementia.

Authors: 
Journal:  CMAJ       Date:  1994-03-15       Impact factor: 8.262

10.  The safety and efficacy of clozapine in severe treatment-resistant schizophrenic patients in the UK. Clozapine Study Group.

Authors: 
Journal:  Br J Psychiatry       Date:  1993-08       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.